Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).
Google Scholar
Franceschi, E. et al. Rare primary central nervous system tumors in adults: an overview. Front. Oncol. 10, 996 (2020).
Google Scholar
Louis, D. N. et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 131, 803–820 (2016).
Google Scholar
Diaz, M., Jo, J., Smolkin, M., Ratcliffe, S. J. & Schiff, D. Risk of venous thromboembolism in grade II-IV gliomas as a function of molecular subtype. Neurology 96, e1063–e1069 (2021).
Google Scholar
Weller, M. et al. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. Lancet Oncol. 18, e315–e329 (2017).
Google Scholar
Garlanda, C., Dinarello, C. A. & Mantovani, A. The interleukin-1 family: back to the future. Immunity 39, 1003–1018 (2013).
Google Scholar
Mantovani, A., Dinarello, C. A., Molgora, M. & Garlanda, C. Interleukin-1 and related cytokines in the regulation of inflammation and immunity. Immunity 50, 778–795 (2019).
Google Scholar
Nakanishi, K., Yoshimoto, T., Tsutsui, H. & Okamura, H. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19, 423–474 (2001).
Google Scholar
Nakanishi, K. Unique action of Interleukin-18 on T cells and other immune cells. Front. Immunol. 9, 763 (2018).
Google Scholar
Yasuda, K., Nakanishi, K. & Tsutsui, H. Interleukin-18 in health and disease. Int. J. Mol. Sci. 20, 649 (2019).
Google Scholar
Zhou, T. et al. IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy. Nature 583, 609–614 (2020).
Google Scholar
Simpson, S., Kaislasuo, J., Guller, S. & Pal, L. Thermal stability of cytokines: a review. Cytokine 125, 154829 (2020).
Google Scholar
Zhang, J. et al. Triazoles as T(2)-exchange Magnetic Resonance Imaging contrast agents for the detection of Nitrilase activity. Chemistry 24, 15013–15018 (2018).
Google Scholar
Cai, X. et al. N-Aryl Amides as chemical exchange saturation transfer Magnetic Resonance Imaging contrast agents. Chemistry 26, 11705–11709 (2020).
Google Scholar
Makanyanga, J. et al. MRI texture analysis (MRTA) of T2-weighted images in Crohn’s disease may provide information on histological and MRI disease activity in patients undergoing ileal resection. Eur. Radiol. 27, 589–597 (2017).
Google Scholar
Li, M. et al. Computed tomography texture analysis to facilitate therapeutic decision making in hepatocellular carcinoma. Oncotarget 7, 13248–13259 (2016).
Google Scholar
Korenchan, D. E. et al. (31)P spin-lattice and singlet order relaxation mechanisms in pyrophosphate studied by isotopic substitution, field shuttling NMR, and molecular dynamics simulation. Phys. Chem. Chem. Phys. 24, 24238–24245 (2022).
Google Scholar
Li, Z. et al. Texture-based classification of different single liver lesion based on SPAIR T2W MRI images. BMC Med. imaging 17, 42 (2017).
Google Scholar
Park, J. E. et al. Radiomics prognostication model in glioblastoma using diffusion- and perfusion-weighted MRI. Sci. Rep. 10, 4250 (2020).
Google Scholar
Choi, Y. S. et al. Incremental prognostic value of ADC histogram analysis over MGMT promoter methylation status in patients with glioblastoma. Radiology 281, 175–184 (2016).
Google Scholar
Kesari, S. et al. Phase II study of protracted daily temozolomide for low-grade gliomas in adults. J. Am. Assoc. Cancer Res. 15, 330–337 (2009).
Claus, E. B. & Verhaak, R. G. W. Targeting IDH in low-grade glioma. N. Engl. J. Med. 389, 655–659 (2023).
Google Scholar
Leu, S., von Felten, S., Frank, S., Boulay, J. L. & Mariani, L. IDH mutation is associated with higher risk of malignant transformation in low-grade glioma. J. Neuro-Oncol. 127, 363–372 (2016).
Google Scholar
Kinslow, C. J. et al. Association of MGMT promoter methylation with survival in low-grade and anaplastic gliomas after alkylating chemotherapy. JAMA Oncol. 9, 919–927 (2023).
Google Scholar
Everhard, S. et al. MGMT methylation: a marker of response to temozolomide in low-grade gliomas. Ann. Neurol. 60, 740–743 (2006).
Google Scholar
Liu, S. et al. NK cell-based cancer immunotherapy: from basic biology to clinical development. J. Hematol. Oncol. 14, 7 (2021).
Google Scholar
Chapman, N. M., Boothby, M. R. & Chi, H. Metabolic coordination of T cell quiescence and activation. Nat. Rev. Immunol. 20, 55–70 (2020).
Google Scholar
Berg, R. E., Cordes, C. J. & Forman, J. Contribution of CD8+ T cells to innate immunity: IFN-gamma secretion induced by IL-12 and IL-18. Eur. J. Immunol. 32, 2807–2816 (2002).
Google Scholar
Freeman, C. M. et al. Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15. J. Immunol.184, 6504–6513 (2010).
Google Scholar
Deswaerte, V. et al. Inflammasome adaptor ASC suppresses apoptosis of gastric cancer cells by an IL18-mediated inflammation-independent mechanism. Cancer Res. 78, 1293–1307 (2018).
Google Scholar
Jarry, A. et al. Role of the inflammasome of tumor cells in modulating the biology of Tumor Infiltrating Lymphocytes (TILs) in colorectal cancer. J. Clin. Oncol. 35, e23087-e23087 (2017).
Wang, X. et al. The prognostic value and immune correlation of IL18 expression and promoter methylation in renal cell carcinoma. Clin. Epigenet.15, 14 (2023).
Google Scholar
American Association for Cancer Research. IL18 promotes MDSC-mediated immunosuppression in multiple myeloma. Cancer Discov. 8, OF12-OF12 (2018).
Bied, M., Ho, W. W., Ginhoux, F. & Blériot, C. Roles of macrophages in tumor development: a spatiotemporal perspective. Cell. Mol. Immunol. 20, 983–992 (2023).
Google Scholar
Wang, L. J., Xue, Y. & Lou, Y. Tumor-associated macrophages related signature in glioma. Aging 14, 2720–2735 (2022).
Google Scholar
Xu, C. et al. Origin, activation, and targeted therapy of glioma-associated macrophages. Front. Immunol. 13, 974996 (2022).
Google Scholar
Lambin, P. et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur. J. Cancer 48, 441–446 (2012).
Google Scholar
Lambin, P. et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat. Rev. Clin. Oncol. 14, 749–762 (2017).
Google Scholar
Kumar, V. et al. Radiomics: the process and the challenges. Magn. Reson. Imaging 30, 1234–1248 (2012).
Google Scholar
Gillies, R. J., Kinahan, P. E. & Hricak, H. Radiomics: images are more than pictures, they are data. Radiology 278, 563–577 (2016).
Google Scholar
Rios Velazquez, E. et al. Somatic mutations drive distinct imaging phenotypes in lung cancer. Cancer Res. 77, 3922–3930 (2017).
Google Scholar
Ameli, S. et al. Role of MRI-derived radiomics features in determining degree of tumor differentiation of hepatocellular carcinoma. Diagnostics12, 2386 (2022).
Google Scholar
Liang, W. et al. Classification prediction of pancreatic cystic neoplasms based on radiomics deep learning models. BMC Cancer 22, 1237 (2022).
Google Scholar
Song, J. et al. Non-small cell lung cancer: quantitative phenotypic analysis of CT images as a potential marker of prognosis. Sci. Rep. 6, 38282 (2016).
Google Scholar
Liu, Z. et al. The applications of radiomics in precision diagnosis and treatment of oncology: opportunities and challenges. Theranostics 9, 1303–1322 (2019).
Google Scholar
Petrick, L. M. & Shomron, N. AI/ML-driven advances in untargeted metabolomics and exposomics for biomedical applications. Cell Rep. Phys. Sci. 3, 100978 (2022).
Google Scholar
Toh, T. S., Dondelinger, F. & Wang, D. Looking beyond the hype: applied AI and machine learning in translational medicine. EBioMedicine 47, 607–615 (2019).
Google Scholar
Yu, Y. et al. Development and validation of a preoperative magnetic resonance imaging radiomics-based signature to predict axillary lymph node metastasis and disease-free survival in patients with early-stage breast cancer. JAMA Netw. Open 3, e2028086 (2020).
Google Scholar
Lv, L. et al. Radiomic analysis for predicting prognosis of colorectal cancer from preoperative (18)F-FDG PET/CT. J. Transl. Med. 20, 66 (2022).
Google Scholar
Amatya, A. K. et al. Subgroup analyses in oncology trials: regulatory considerations and case examples. J. Am. Assoc. Cancer Res. 27, 5753–5756 (2021).
Hänzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).
Google Scholar
Hong, F. et al. Single-cell analysis of the pan-cancer immune microenvironment and scTIME portal. Cancer Immunol. Res. 9, 939–951 (2021).
Google Scholar
Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).
Google Scholar
Jiang, P. et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat. Med. 24, 1550–1558 (2018).
Google Scholar
Mandrekar, J. N. Receiver operating characteristic curve in diagnostic test assessment. J. Thorac. Oncol.5, 1315–1316 (2010).
Google Scholar
Zhang, L. et al. Multicenter clinical radiomics-integrated model based on [(18)F]FDG PET and multi-modal MRI predict ATRX mutation status in IDH-mutant lower-grade gliomas. Eur. Radiol. 33, 872–883 (2023).
Google Scholar
Jung, S. H. Stratified Fisher’s exact test and its sample size calculation. Biom. J. 56, 129–140 (2014).
Google Scholar
Ballenberger, N., Lluis, A., von Mutius, E., Illi, S. & Schaub, B. Novel statistical approaches for non-normal censored immunological data: analysis of cytokine and gene expression data. PloS ONE 7, e46423 (2012).
Google Scholar
Seiler, R. et al. Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy. Eur. Urol. 72, 544–554 (2017).
Google Scholar
